New concepts in organ transplantation

Transplantation Proceedings

Volumn 36, Issue 5, 2004, Pages 1232-1234

  Paczek, L ^a   Pawlowska, M ^a   Krawczyk, M ^a   Rowinski, W ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND MONOCLONAL ANTIBODY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HYBRID PROTEIN; IMMUNOSUPPRESSIVE AGENT;

BONE MARROW TRANSPLANTATION; CHRONIC GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; HYPERACUTE GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; INTESTINE GRAFT; LUNG TRANSPLANTATION; NONHUMAN; ORGAN DONOR; ORGAN TRANSPLANTATION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; SHORT SURVEY; TOXICITY; XENOTRANSPLANTATION;

EID: 3142640641     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.05.051     Document Type: Article

References (12)

1. Lehnert A.M., Yi S., Burgess J.S., et al. Pancreatic islet xenograft tolerance after short-term costimulation blockade is associated with increased CD4+ T cell apoptosis but not immune deviation. Transplantation. 69:2000;1176
2. Herwartz C., Steimann J., Bethke U., et al. Rejection prophylaxis with interleukin-2 receptor antibody BT 563 mechanisms of action on human cells. Transpl Int. 5:1992;684
3. Guillot C., Menoret S., Guillonneau C., et al. Active suppression of allogenic proliferative responses by dendritic cells after induction of long-term allograft survival by CTLA4Ig. Blood. 101:2003;3325
4. Gammie J.S., Pham S.M. Simultaneous donor bone marrow and cardiac transplantation can tolerance be induced with the development of chimerism? Curr Opin Cardiol. 14:1999;126
5. De Pauw L., Toungouz M., Goldman M. Infusion of donor-derived hematopoietic stem cells in organ transplantation clinical data. Transplantation. 75:2003;46
6. Burke G.W., Ciancio G., Garcia-Morales R., et al. Higher percentage of donor CD 34+ expression in peripheral blood of simultaneous pancreas/kidney/ donor bone marrow versus than kidney/islet cell/donor bone marrow recipients. Transplant Proc. 30:1998;535
7. Mollnes T.E., Fiane A.E. Perspectives on complement in xenotransplantation. Mol Immunol. 40:2003;135
8. Lin S.S., Hanaway M.J., Gonzalez-Stawinski G.V., et al. The role of anti-Galalpha 1, 3 Gal antibodies in acute vascular rejection and accomodation of xenografts. Transplantation. 70:2000;1667
9. Cappello F., Bellafiore M., Palma A., et al. Protective role of the complement regulatory protein human CD-55 in cardiac xenograft a descriptive study and a revision of the literature. Histol Histopathol. 17:2002;1085
10. Costa C., Zhao L., Burton W.V., et al. Transgenic pigs destined to express human CD59 and H-transferase to avoid humoral xenograft rejection. Xenotransplantation. 9:2002;45
11. Lee J.M., Tu C.F., Yang P.W., et al. Reduction of human-to-pig cellular response by alteration of porcine MHC with human HLA DPW0401 exogenes. Transplantation. 73:2002;193
12. Langat D.K., Mwenda J.M. Potential risks of viral infections in xenotransplantation. Acta Trop. 76:2000;147